ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Investigation of anti-microbial and cytotoxic potential of Streptomyces werraensis GRS9 derived from the sediments of river Ganga.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the present work was to screen bacterial and actinomycetes strains from the sediments of river Ganga (India) as a promising source of anti-microbial and anti-cancer agents along with spectroscopic and chromatographic identification of bio-active compounds. The strain GRS9 exhibited broad-spectrum bio-activity against all the 15-test organisms incorporated in our study with minimum inhibitory concentrations (MICs) ranging from 16 µg/ml against Staphylococcus aureus MTCC3160 to 500 μg/ml for Escherichia coli (MTCC118). The cytotoxic profile of ethyl acetate extract was also evaluated against Human Colon Cancer Cell Line (HCT116) by Neutral Red Uptake (NRU) assay, followed by in silico study to determine its pre-qualification for drug suitability. The results indicated that Streptomyces werraensis GRS9 extract possessed anti-cancer properties (IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.